Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Regencell Bioscience Holdings Limited (RGC) had Tangible Shareholders Equity of $4.86M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$4.90M |
|
$1.07M |
|
$1.17M |
|
$5.76M |
|
$0.66M |
|
-- |
|
-- |
|
$0.90M |
|
$4.86M |
|
|
Tangible Shareholders Equity |
$4.86M |
$4.86M |
|
-- |
|
| Cash Flow Statement Financials | |
$-3.11M |
|
$2.69M |
|
$0.00M |
|
$2.96M |
|
$2.42M |
|
$-0.54M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|